Literature DB >> 30907586

Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence: Data-Driven and Mechanism-Driven Modeling for Chemical Toxicity.

Heather L Ciallella, Hao Zhu.   

Abstract

In 2016, the Frank R. Lautenberg Chemical Safety for the 21st Century Act became the first US legislation to advance chemical safety evaluations by utilizing novel testing approaches that reduce the testing of vertebrate animals. Central to this mission is the advancement of computational toxicology and artificial intelligence approaches to implementing innovative testing methods. In the current big data era, the terms volume (amount of data), velocity (growth of data), and variety (the diversity of sources) have been used to characterize the currently available chemical, in vitro, and in vivo data for toxicity modeling purposes. Furthermore, as suggested by various scientists, the variability (internal consistency or lack thereof) of publicly available data pools, such as PubChem, also presents significant computational challenges. The development of novel artificial intelligence approaches based on public massive toxicity data is urgently needed to generate new predictive models for chemical toxicity evaluations and make the developed models applicable as alternatives for evaluating untested compounds. In this procedure, traditional approaches (e.g., QSAR) purely based on chemical structures have been replaced by newly designed data-driven and mechanism-driven modeling. The resulting models realize the concept of adverse outcome pathway (AOP), which can not only directly evaluate toxicity potentials of new compounds, but also illustrate relevant toxicity mechanisms. The recent advancement of computational toxicology in the big data era has paved the road to future toxicity testing, which will significantly impact on the public health.

Entities:  

Mesh:

Year:  2019        PMID: 30907586      PMCID: PMC6688471          DOI: 10.1021/acs.chemrestox.8b00393

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  17 in total

Review 1.  Developing novel in vitro methods for the risk assessment of developmental and placental toxicants in the environment.

Authors:  Rebecca C Fry; Jacqueline Bangma; John Szilagyi; Julia E Rager
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-22       Impact factor: 4.219

2.  Mechanism-Driven Read-Across of Chemical Hepatotoxicants Based on Chemical Structures and Biological Data.

Authors:  Linlin Zhao; Daniel P Russo; Wenyi Wang; Lauren M Aleksunes; Hao Zhu
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

Review 3.  Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

Authors:  Linlin Zhao; Heather L Ciallella; Lauren M Aleksunes; Hao Zhu
Journal:  Drug Discov Today       Date:  2020-07-11       Impact factor: 7.851

Review 4.  Big Data and Artificial Intelligence Modeling for Drug Discovery.

Authors:  Hao Zhu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-13       Impact factor: 13.820

5.  Automatic Quantitative Structure-Activity Relationship Modeling to Fill Data Gaps in High-Throughput Screening.

Authors:  Heather L Ciallella; Elena Chung; Daniel P Russo; Hao Zhu
Journal:  Methods Mol Biol       Date:  2022

6.  Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay.

Authors:  Xuelian Jia; Xia Wen; Daniel P Russo; Lauren M Aleksunes; Hao Zhu
Journal:  J Hazard Mater       Date:  2022-05-20       Impact factor: 14.224

Review 7.  Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.

Authors:  Neetu Tripathi; Manoj Kumar Goshisht; Sanat Kumar Sahu; Charu Arora
Journal:  Mol Divers       Date:  2021-06-10       Impact factor: 2.943

Review 8.  FutureTox IV Workshop Summary: Predictive Toxicology for Healthy Children.

Authors:  Thomas B Knudsen; Suzanne Compton Fitzpatrick; K Nadira De Abrew; Linda S Birnbaum; Anne Chappelle; George P Daston; Dana C Dolinoy; Alison Elder; Susan Euling; Elaine M Faustman; Kristi Pullen Fedinick; Jill A Franzosa; Derik E Haggard; Laurie Haws; Nicole C Kleinstreuer; Germaine M Buck Louis; Donna L Mendrick; Ruthann Rudel; Katerine S Saili; Thaddeus T Schug; Robyn L Tanguay; Alexandra E Turley; Barbara A Wetmore; Kimberly W White; Todd J Zurlinden
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

Review 9.  Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Authors:  José T Moreira-Filho; Arthur C Silva; Rafael F Dantas; Barbara F Gomes; Lauro R Souza Neto; Jose Brandao-Neto; Raymond J Owens; Nicholas Furnham; Bruno J Neves; Floriano P Silva-Junior; Carolina H Andrade
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

10.  Revealing Adverse Outcome Pathways from Public High-Throughput Screening Data to Evaluate New Toxicants by a Knowledge-Based Deep Neural Network Approach.

Authors:  Heather L Ciallella; Daniel P Russo; Lauren M Aleksunes; Fabian A Grimm; Hao Zhu
Journal:  Environ Sci Technol       Date:  2021-07-25       Impact factor: 11.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.